Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Glenmark Life Sciences Ltd.

NSE: GLS | BSE:543322

₹911.70 -13.65 (-1.48%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

907.00

Today’s High

947.30

52W low

564.30

52W High

972.00

Open Price

935.00

Prev. Close

855.2500

Volume

99957.00

Value

91130796.90

Fundamentals

Market Cap Cr

11170.80

Price to Earnings

23.70

Price to Book Value

4.80

Dividend Yield

2.50

PE to Growth

28.20

Op Revenue TTM Cr

2283.21

Net Profit TTM Cr

470.89

Cash From Operating Activity Cr

413.52

Return on Equity %

20.18

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

895.5

10Day EMA

878.1

12Day EMA

874

20Day EMA

863.3

26Day EMA

858

50Day EMA

842.8

100Day EMA

815.1

200Day EMA

757.2

5Day SMA

895.6

10Day SMA

864.2

20Day SMA

861.3

30Day SMA

851.3

50Day SMA

839.9

100Day SMA

825.5

150Day SMA

789.4

200Day SMA

749

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

04 Jul, 2024

45.3

Week

34.7

Month

41.8

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

921.98

PIVOT

First Resistance

937.02

Second Resistance

962.33

Third Resistance

977.37

First Support

896.67

Second Support

881.63

Third Support

856.32

Relative Strength Index

65.78

Money Flow Index

74.09

MACD

16.01

MACD Signal

8.92

Average True Range

33.86

Average Directional Index

24.42

Rate of Change (21)

10.38

Rate of Change (125)

27.65

Commodity Channel Index

206.7

Williams %R

-40.7

BETA

1 Month

0.38

3 Month

0.23

1 Year

0.3

3 Year

PRICE CHANGE ANALYSIS

↑ 8.21%

1 Week

Low

High

829.1

972

↑ 8.55%

1 Month

Low

High

755.95

972

↑ 14.39%

3 Months

Low

High

743.85

972

↑ 24.91%

6 Months

Low

High

676.5

972

↑ 58.83%

1 Year

Low

High

564.3

972

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 539.73 574.50 600.73 580.30 624.16 547.34 519.32 499.36 519.15 526.03 563.85
Operating Expenses Qtr 395.15 400.25 428.28 385.29 414.89 395.27 365.66 343.10 371.85 376.44 394.42
Operating Profit Qtr 141.45 172.56 167.08 193.16 206.43 145.46 143.64 146.77 142.21 146.06 167.34
EBIDT Qtr Cr 144.58 174.25 172.45 195.01 209.27 152.06 153.66 156.26 147.31 149.60 169.43
Depreciation Qtr 14.53 13.18 13.13 12.61 11.52 10.76 9.94 9.88 9.55 9.74 9.66
Net Profit Qtr 97.94 118.77 118.74 135.45 146.36 104.99 106.88 108.73 98.90 103.71 115.20
Basic EPS Qtr 7.99 9.69 9.69 11.05 11.94 8.57 8.72 8.87 8.07 8.65 9.83
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 2295.26 2190.18 2137.92 1885.98 1549.30
Operating Expenses Annual Cr 1608.97 1518.93 1507.15 1294.09 1065.35
Operating Profit Annual 674.25 642.29 616.06 591.07 471.96
Operating Profit Margin Annual % 29.38 29.33 28.82 31.34 30.46
Total Expenses Annual Cr 1663.97 1561.57 1572.99 1415.03 1128.24
EBIDT Annual Cr 686.29 671.25 630.76 591.88 483.95
EBIDT Annual margin % 29.90 30.65 29.50 31.38 31.24
Depreciation 53.45 42.09 37.88 33.39 29.37
PAT Before ExtraOrdinary Items Annual Cr 470.89 466.96 418.72 351.58 313.10
Net Profit Annual 470.89 466.96 418.72 351.58 313.10
Basic EPS Annual 38.43 38.11 35.63 32.61 1597.37
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 2332.32 2138.21 2054.31 752.75 401.69
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 79.32 59.53 32.70 22.89 16.45
Total Current Liabilities Annual Cr 438.77 504.41 384.00 1221.44 1307.46
Total Capital Plus Liabilities Annual Cr 2850.41 2702.15 2471.01 1997.08 1725.60
Fixed Assets Annual 911.05 842.25 686.72 586.90 556.98
Total Non Current Assets Annual 934.41 851.81 706.42 598.03 565.49
Total Current Assets Annual 1916.00 1850.34 1764.58 1399.04 1160.11
Total Assets Annual 2850.41 2702.15 2471.01 1997.08 1725.60
Contingent Liabilities plus Commitments Annual Cr 12.83 12.83 50.42 17.23 38.93
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 413.51 313.40 597.59 388.11 195.01
Cash from Investing Activity Annual -116.48 -154.15 -122.23 -68.73 -50.52
Cash from Financing Annual Activity -279.44 -387.59 -78.80 -213.78 -136.55
Net Cash Flow Annual - -228.33 396.56 105.60 7.94
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 190.35 174.51 167.66 768.11 2049.45
ROE Annual % 20.18 21.83 20.38 46.70 77.94
ROCE Annual % 26.24 28.62 28.40 72.00 108.71
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 30.05 31.05 29.70 31.39 31.48
Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Graph
Total Revenue Annual
Operating Expenses Annual Cr
Operating Profit Annual
Operating Profit Margin Annual %
Total Expenses Annual Cr
EBIDT Annual Cr
EBIDT Annual margin %
Depreciation
PAT Before ExtraOrdinary Items Annual Cr
Net Profit Annual
Basic EPS Annual
Indicator Graph
Total ShareHolders Funds Annual
Minority Interest Liability Annual Cr
Total Non Current Liabilities Annual Cr
Total Current Liabilities Annual Cr
Total Capital Plus Liabilities Annual Cr
Fixed Assets Annual
Total Non Current Assets Annual
Total Current Assets Annual
Total Assets Annual
Contingent Liabilities plus Commitments Annual Cr
Indicator Graph
Cash from Operating Activity Annual
Cash from Investing Activity Annual
Cash from Financing Annual Activity
Net Cash Flow Annual
Indicator Graph
Book Value Per Share Annual
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual
EBDIT Annual Margin %
Name Holding Percent Holding Id Pledged % Locked %
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 1.43 75061889 - -
Name Holding Percent Holding Id Pledged % Locked %
NIRMA LIMITED 75 75061882 0 26.67
GLENMARK PHARMACEUTICALS LIMITED 7.84 75061883 100 0
Name Holding Percent Holding Id
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 1.43 75061889
Name Holding Percent Holding Id
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Oct 17, 2023 22.5 INTERIM Oct 17, 2023 Equity Share
Mar 24, 2023 21 INTERIM Mar 24, 2023 Equity Share
Sep 15, 2022 10.5 FINAL - Equity Share
Nov 22, 2021 10.5 INTERIM Nov 23, 2021 Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
Apr 25, 2024 Audited Results -
Jan 23, 2024 Quarterly Results -
Oct 20, 2023 Quarterly Results -
Oct 09, 2023 Interim Dividend -
Jul 21, 2023 Quarterly Results -
Apr 27, 2023 Audited Results -
Mar 16, 2023 Interim Dividend -
Jan 27, 2023 Quarterly Results -
Oct 21, 2022 Quarterly Results -
Aug 04, 2022 Quarterly Results -
Apr 20, 2022 Audited Results & Final Dividend -
Feb 08, 2022 Quarterly Results -
Nov 10, 2021 Quarterly Results -
Ex-Date Bonus Ratio Record Date
Bigul
04 Jul 2024

Glenmark Life Sciences Ltd - 543322 - Disclosure under Regulation 30A of LODR

 Please find attached intimation under Regulation 30A of SEBI LODR 2015
Bigul
21 Jun 2024

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 With reference to the captioned subject and pursuant to Regulation 30 and Para A of Part A of Schedule III of SEBI (Listing obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Officials of the Company will be participating in 'Kotak Securities' 'Non- Deal Roadshow', virtually and in India from 26th June, 2024 to 28th June, 2024. Note: Date/Participants are subject to changes. Changes may happen due to exigencies on part of Analyst/ institutional Investor/ Company.
Bigul
20 Jun 2024

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Analyst / Investor Meet
Bigul
19 Jun 2024

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Credit Rating

 India Ratings Revises Outlook on Glenmark Life Sciences'' Bank Loans to Positive; Affirms ''IND AA-''; Off Rating Watch with Developing Implications
Bigul
13 Jun 2024

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Analyst / Investor Meet
Bigul
12 Jun 2024

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Intimation of Analyst / Investor Meet
Bigul
03 Jun 2024

Glenmark Life Sciences Ltd - 543322 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

 Please find attached Scrutinizer''s Report with respect to postal ballot.
Bigul
31 May 2024

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Please find attached details of Institutional Investor''s Conference.
Bigul
27 May 2024

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Find attached details of Institutional Investors Conference.
Bigul
16 May 2024

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Please find attached herewith details of analyst/investor meet.
See all News

FAQs

The latest market price of Glenmark Life Sciences Ltd. on NSE was Rs. 911.70 as of today.

The opening share price of Glenmark Life Sciences Ltd. was Rs. 935.00 as of today.

The 52-week high share price of Glenmark Life Sciences Ltd. was Rs. 972.00.

The 52 week low share price of Glenmark Life Sciences Ltd. was Rs. 564.30.

Glenmark Life Sciences Ltd. has a market cap of Rs. 11170.80 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Glenmark Life Sciences Ltd. is 28.20. Please refer to the Fundamentals section for further details.

The operating revenue for Glenmark Life Sciences Ltd. in the last FY was Rs.  2283.21 crore. Please refer to the Financials section for further details.

The Net Profit for Glenmark Life Sciences Ltd. in the last FY was Rs. 470.89 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Glenmark Life Sciences Ltd. was on 2023-10-17 for Rs. 22.5 per share. According to today’s share price, the dividend yield of Glenmark Life Sciences Ltd. stands at 2.50. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Glenmark Life Sciences Ltd..

Close

Let's Open Free Demat Account